|
400 subject sentinel portion of Phase 2b study will evaluate the safety,
immunogenicity and efficacy of Vaxart's next generation oral pill... Clinical trial, Vaccine |
|
| More about this | ||
|
|
||
| ||
|
|
400 subject sentinel portion of Phase 2b study will evaluate the safety,
immunogenicity and efficacy of Vaxart's next generation oral pill... Clinical trial, Vaccine |
|
| More about this | ||
|
|
||
| ||